Network origin in Hannah Fiona Sore first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hannah Fiona Sore via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Cellzome Ltd.
Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Corporate Officer/Principal | |
AgrEvo GmbH
AgrEvo GmbH Chemicals: AgriculturalProcess Industries AgrEvo GmbH manufacturers fertilizer products. It offers crop protection and production products including seeds, pest control products and other bio- technology products. The company is headquartered in Berlin, Germany. | Chemicals: Agricultural | Corporate Officer/Principal | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures (RCT BioVentures) is a venture capital subsidiary of Research Corporation Technologies Inc founded in 1987. The firm is headquartered in Tucson, Arizona. | Investment Managers | Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Masters Business Admin | |
University of New Brunswick | College/University | Undergraduate Degree | |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Private Equity Investor | |
MP Healthcare Venture Management, Inc.
MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture Management, Inc (MP Healthcare Venture) is a venture capital subsidiary of Mitsubishi Tanabe Pharma Corp founded in 2006. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member | |
Harvard Medical School | College/University | Graduate Degree | |
Cambridge Judge Business School | College/University | Masters Business Admin | |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Biotechnology | Director/Board Member | |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Qkine Ltd.
Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Diamond Edge Ventures, Inc.
Diamond Edge Ventures, Inc. Investment ManagersFinance Diamond Edge Ventures, Inc (Diamond Edge ventures) is a venture capital subsidiary of Mitsubishi Chemical Holdings Corp founded in 2018. The firm is headquartered in San Francisco, California. | Investment Managers | Director/Board Member | |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Macomics Ltd.
Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Spirea Ltd.
Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
NanoSyrinx Ltd
NanoSyrinx Ltd Miscellaneous Commercial ServicesCommercial Services NanoSyrinx Ltd is a discovery stage biotechnology company that is based in the UK. The British company is focused on developing protein nanosyringes as a new way to deliver protein and peptide biologic drugs intracellularly. The company uses synthetic biology approaches to achieve this goal. The company was founded by Joseph Healey, Alexia Hapeshi, and Nicholas Waterfield, with Joseph Healey serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
SDS Therapeutics Ltd.
SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Capsigen, Inc.
Capsigen, Inc. BiotechnologyHealth Technology Capsigen, Inc. is a company based in Vancouver, WA that is developing the next generation of AAV vectors for gene therapy. The company's end-to-end platform uses customized, diverse libraries and proprietary trade™ technology to identify fully functional vectors that meet disease-specific transduction criteria. Capsigen's fit-for-purpose vectors are designed to deliver the highest level of clinical utility in a rapid and high-throughput manner. The company uses data science and directed evolution to build custom AAV capsids to move patients from hope to cured. John Bial has been the CEO of the company since 2020. | Biotechnology | Director/Board Member | |
SOLA Biosciences LLC
SOLA Biosciences LLC Pharmaceuticals: MajorHealth Technology SOLA Biosciences LLC is a pre-clinical-stage biopharmaceutical company that develops gene-therapies for patients with neurodegenerative diseases. The company is based in Natick, MA. The company was founded by Akinori Hishiya, Keizo Koya. Keizo Koya has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
United Kingdom | 18 |
United States | 11 |
Austria | 2 |
Germany | 2 |
Canada | 2 |
Sectoral
Health Technology | 17 |
Consumer Services | 6 |
Finance | 6 |
Commercial Services | 4 |
Process Industries | 2 |
Operational
Director/Board Member | 20 |
Corporate Officer/Principal | 12 |
Founder | 5 |
Doctorate Degree | 3 |
Undergraduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Jeffrey Moore | 13 |
Jane Elizabeth Dancer | 11 |
Christine Martin | 11 |
Jelena Aleksic | 2 |
Natalia Mateu | 1 |
Gaynor Mary Fryers | 1 |
David Spring | 1 |
Andreas Bender | 1 |
- Stock Market
- Insiders
- Hannah Fiona Sore
- Company connections